Lentiviral/retroviral vector large scale manufacturing

被引：0

作者：

Bellintani, F. ^{[1
]}

Neri, M. ^{[1
]}

Rossetti, F. ^{[1
]}

Cota, M. ^{[1
]}

Crippa, L. ^{[1
]}

Piovani, B. ^{[1
]}

Simonetti, E. ^{[1
]}

Allievi, L. ^{[1
]}

Corbetta, S. ^{[1
]}

Lorenzetti, F. ^{[1
]}

Testasecca, A. ^{[1
]}

Pedregal, A. ^{[2
]}

Vallanti, G. ^{[1
]}

机构：

[1] MolMed SpA, Milan, Italy

[2] Pall Life Sci, New York, NY USA

来源：

HUMAN GENE THERAPY | 2018年 / 29卷 / 12期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

P457

引用

页码：A158 / A159

页数：2

共 50 条

[41] Development of the Retroviral Vector Manufacturing Process for MM-TK Therapy
Catamancio, Simona La Seta
Cota, Manuela
Mangia, Patrizia
Arnaudova, Ralitsa
Morandi, Paolo
Marzocca, Marisa
Manfredini, Michele
Rossetti, Francesca
Spoldi, Elena
Vallanti, Giuliana
Rizzardi, Gian-Paolo
Traversari, Catia
MOLECULAR THERAPY, 2015, 23 : S268 - S268
[42] Onco-Retroviral and lentiviral vector-based gene therapy for hemophilia: Preclinical studies
Van Damme, A
Chuah, MKL
Collen, D
VandenDriessche, T
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2004, 30 (02): : 185 - 195
[43] Large-Scale Manufacture and Characterization of a Lentiviral Vector Produced for Clinical Ex Vivo Gene Therapy Application
Merten, Otto-Wilhelm
Charrier, Sabine
Laroudie, Nicolas
Fauchille, Sylvain
Dugue, Celine
Jenny, Christine
Audit, Muriel
Zanta-Boussif, Maria-Antonietta
Chautard, Helene
Radrizzani, Marina
Vallanti, Giuliana
Naldini, Luigi
Noguiez-Hellin, Patricia
Galy, Anne
HUMAN GENE THERAPY, 2011, 22 (03) : 343 - 356
[44] Adaptation of a lentiviral vector producer cell line to reduced-serum, suspension culture for large scale production
Townsend, K
Chen, Y
Dayao, J
Farson, D
Miller, WM
Lin, A
MOLECULAR THERAPY, 2004, 9 : S33 - S33
[45] Development of novel lipoplex formulation methodologies to improve large-scale transient transfection for lentiviral vector manufacture
Williams-Fegredo, Thomas
Davies, Lee
Knevelman, Carol
Mitrophanous, Kyriacos
Miskin, James
Rafiq, Qasim A.
MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (02)
[46] Advantages of Standardization and Large-Scale Manufacturing of Helper Plasmids for Viral Vector Production
Grasswick, Cody
Reames, Robert
Keller, Luise-Elektra
Page, Emma
Liu, Qian
Muranaka, Janelle
Gelinske, Meagan
Spangler, Nate
Brown, James
Whalen, Robert
Hebel, Henry
Ballantyne, John
Chambers, Michael
MOLECULAR THERAPY, 2019, 27 (04) : 345 - 346
[47] Advantages of standardization and large-scale manufacturing of helper plasmids for viral vector production
Grasswick, C.
Reames, R.
Keller, L. E.
Page, E.
Liu, Q.
Muranaka, J.
Gelinske, M.
Spangler, N.
Brown, J.
Whalen, R.
Hebel, H.
Ballantyne, J.
Chambers, M.
Krusen, M.
HUMAN GENE THERAPY, 2019, 30 (11) : A42 - A42
[48] Insertional mutagenesis by retroviral and lentiviral vectors
Knight, Sean
Bokhoven, Marieke
Gupta, Abhinav
Ceylan, Mustafa
Zhang, Fang
Antoniou, Michael
Thrasher, Adrian
Takeuchi, Yasuhiro
Collins, Mary
HUMAN GENE THERAPY, 2008, 19 (10) : 1190 - 1190
[49] Insertional mutagenesis by retroviral and lentiviral vectors
Bokhoven, Marieke
Stephen, Sam
Takeuchi, Yasuhiro
Collins, Mary K.
HUMAN GENE THERAPY, 2007, 18 (10) : 958 - 958
[50] Simplified Large-Scale Production of Lentiviral Vectors
Hollis, Roger P.
Senadheera, Shantha
Skelton, Dianne
Kohn, Donald B.
MOLECULAR THERAPY, 2009, 17 : S272 - S272

← 1 2 3 4 5 →